Source comparison
Melanotan-2 Legal 2026 Status: Comparison Table
United States (Federal) Unapproved new drug (21 USC 355) Yes (no controlled substance status) No (marketing as drug/cosmetic violates FDCA) Targets suppliers making tanning claims; minimal end-user enforcement Legal gray area. Possession not criminalized, but
This comparison does not assign a generated winner or score.
- United States (Federal)
- Unapproved new drug (21 USC 355)
- Yes (no controlled substance status)
- No (marketing as drug/cosmetic violates FDCA)
- Targets suppliers making tanning claims; minimal end-user enforcement
- Legal gray area. Possession not criminalized, but no regulatory protection
- United Kingdom
- Unlicensed medicinal product
- Yes
- No
- Sporadic enforcement against online sellers
- Illegal to sell, but possession rarely prosecuted
- Australia
- Prohibited import (Schedule 4 prescription medicine)
- No (civil penalties apply)
- Active customs seizure; medical board discipline for prescribers
- Strictest enforcement. Importation carries fines
- European Union
- No EMA approval (member state regulation)
- Varies by country
- Highly variable. Nordic countries strict, Southern Europe lenient
- Fragmented approach creates enforcement inconsistency
- Canada
- Unapproved drug (Health Canada)
- Warning letters to suppliers; no criminal prosecution for possession
- Similar to US. Regulatory rather than criminal framework